Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.2M Buy
77,004
+27,464
+55% +$5.45M 0.45% 37
2026
Q1
$7.29M Sell
49,540
-790
-2% -$116K 0.17% 126
2025
Q4
$6.12M Buy
50,330
+26,760
+114% +$3.14M 0.13% 165
2025
Q3
$2.54M Sell
23,570
-1,100
-4% -$103K 0.08% 231
2025
Q2
$2.21M Buy
24,670
+17,960
+268% +$1.35M 0.07% 261
2025
Q1
$456K Sell
6,710
-3,180
-32% -$229K 0.03% 344
2024
Q4
$623K Buy
9,890
+3,760
+61% +$254K 0.04% 327
2024
Q3
$475K Buy
6,130
+340
+6% +$26.7K 0.08% 108
2024
Q2
$477K Buy
+5,790
New +$428K 0.09% 87

Other funds holding KLAC

Callan Family Office's KLAC Position: Q2 2026 in Review

Callan Family Office increased its KLA (KLAC) stake by 55% in Q2 2026, buying an estimated $5.45M and bringing the position to 77,004 shares worth $23.2M. The position accounts for 0.45% of the portfolio, ranked #37.

Callan Family Office first reported a position in KLAC in Q2 2024 and has held it in 9 quarters since. 2,491 funds tracked by Wall St. Rank hold KLAC as of Q2 2026.

  • Callan Family Office held 77,004 shares of KLA worth $23.2M as of Q2 2026.
  • Callan Family Office bought 27,464 KLA shares in Q2 2026, an estimated $5.45M.
  • KLA made up 0.45% of Callan Family Office's portfolio in Q2 2026, its #37 holding.
  • Callan Family Office first reported a position in KLA in Q2 2024 and has held it in 9 quarters since.
  • 2,491 funds tracked by Wall St. Rank held KLA as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.